Thus, it is possible that an AVP-induced TRPC3 translocation would augment CD Ca2+ reabsorption to decrease a risk of nephrocalcinosis and urolithiasis by preventing Ca2+ precipitation in the luminal fluid during robust water reabsorption in the CD. The gene discussed is TRPC3; the disease is nephrocalcinosis.